Pfizer stock slips before the bell as 2026 drug price hikes put PFE back in focus
NEW YORK, Jan 2, 2026, 09:18 ET — Premarket Pfizer Inc shares fell 0.4% to $24.90 in premarket trading on Friday after a Reuters report said the drugmaker plans to raise U.S. list prices on around 80 medicines in 2026. Reuters The pricing moves matter now because January is when drugmakers typically reset U.S. list prices, a closely watched “sticker…